Enabling Integrated and Flexible Manufacturing for Adherent and Suspension Cell Therapies
The path from bench to bedside relies not just on research, but on robust,
scalable infrastructure and compliant manufacturing processes.
As part of the 𝗔𝗖𝗧𝗥𝗜𝗦 𝗦𝗶𝗴𝗻𝗮𝘁𝘂𝗿𝗲 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗦𝗲𝗿𝗶𝗲𝘀
𝟮𝟬𝟮𝟱, we are pleased to present our September run of Joint-Lab Workshop
with Terumo Blood and Cell Technologies -
𝗘𝗻𝗮𝗯𝗹𝗶𝗻𝗴 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝗱 𝗮𝗻𝗱 𝗙𝗹𝗲𝘅𝗶𝗯𝗹𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴
𝗳𝗼𝗿 𝗔𝗱𝗵𝗲𝗿𝗲𝗻𝘁 𝗮𝗻𝗱 𝗦𝘂𝘀𝗽𝗲𝗻𝘀𝗶𝗼𝗻 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀.
🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://for.sg/actris-signature-workshop-series-terumobct-sep2025
⏳ 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗰𝗹𝗼𝘀𝗲𝘀 𝗙𝗿𝗶𝗱𝗮𝘆, 𝟱 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟱
This full-day, in-person workshop will offer hands-on demonstrations,
expert-led sessions, and practical case studies that walk through every
stage of the cell therapy manufacturing process — from cell collection
to expansion and fill & finish.
🔍 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀
1️⃣ 𝗦𝗽𝗲𝗰𝘁𝗿𝗮 𝗢𝗽𝘁𝗶𝗮™ 𝗔𝗽𝗵𝗲𝗿𝗲𝘀𝗶𝘀 𝗦𝘆𝘀𝘁𝗲𝗺
A flexible, multi-procedure platform that streamlines cell collection
and processing through continuous-flow centrifugation and optical detection
technology.
2️⃣ 𝗤𝘂𝗮𝗻𝘁𝘂𝗺 𝗙𝗹𝗲𝘅™ 𝗖𝗲𝗹𝗹 𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺
A closed, automated system that simplifies cell expansion while supporting
scalability and regulatory compliance.
3️⃣ 𝗙𝗜𝗡𝗜𝗔™ 𝗙𝗶𝗹𝗹 𝗮𝗻𝗱 𝗙𝗶𝗻𝗶𝘀𝗵 𝗦𝘆𝘀𝘁𝗲𝗺
Purpose-built to automate the final step in cell therapy manufacturing,
reducing product variability and contamination risk.
𝗧𝗿𝗮𝗶𝗻𝗲𝗿𝘀:
• Louise Tan (PhD),
Field Application Scientist Supervisor, APAC
• Desmond Chia,
CTT Field Application Scientist, APAC
🎯 𝗪𝗵𝗼 𝘀𝗵𝗼𝘂𝗹𝗱 𝗮𝘁𝘁𝗲𝗻𝗱:
Researchers and Professionals in cell and gene therapy, immunotherapy,
and manufacturing seeking innovative solutions to advance and improve cell
therapy production processes.